Saniona AB (STU:30S) Beta: 2.1222 (As of Jun. 26, 2026)


STU:30S Saniona AB STU:30S
61 GF Score
Price €1.13
GF Value €2.44
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Beta?

Saniona AB STU:30S +1.34% 61 Beta is 2.1222 as of Jun. 26, 2026. GuruFocus rates STU:30S with a GF Score™ of 61/100 and a GF Value™ of €2.44 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Saniona AB's Beta is 2.1222.


Saniona AB  (STU:30S) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Saniona AB Beta Related Terms


Saniona AB Beta Historical Data

* Premium members only.

The historical data trend for Saniona AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB Beta Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.55 0.35 -1.05 0.01

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 1.62 1.13 0.01 2.35

STU:30S vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Saniona AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saniona AB Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's Beta distribution charts can be found below:

* The bar in red indicates where Saniona AB's Beta falls into.


STU:30S
61GF Score
Saniona AB STU:30S
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.1222 mean?
Saniona AB (STU:30S) has a Beta of 2.1222 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Saniona AB and its competitors.
Is Saniona AB's Beta too high?
Saniona AB's current Beta is 2.1222. Overall, Saniona AB has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's Beta compare to VRTX and REGN?
Saniona AB's Beta of 2.1222 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Saniona AB and its competitors. Saniona AB's current Beta is 2.1222. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (STU:30S) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.44, compared to a current price of €1.13 — trading 53.6% below its estimated fair value. The current Beta is 2.1222. Saniona AB's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Saniona AB (STU:30S), the current Beta is 2.1222 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (STU:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.13 is trading 53.6% below its estimated GF Value™ of €2.44. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for STU:30S:

  • Beta: 2.1222
  • GF Value™: €2.44 vs. price of €1.13 (53.6% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the STU:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
61GF Score

Get the complete analysis for STU:30S

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.13
Price
€2.44
GF Value